Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Low molecular weight heparins for current and future uses: approaches for micro- and nano-particulate delivery.

Ibrahim SS, Osman R, Awad GA, Mortada ND, Geneidy AS.

Drug Deliv. 2015 Jun 16:1-7. [Epub ahead of print]

PMID:
26056721
2.

Defining cisplatin incorporation properties in thermosensitive injectable biodegradable hydrogel for sustained delivery and enhanced cytotoxicity.

Abdel-Bar HM, Abdel-Reheem AY, Osman R, Awad GA, Mortada N.

Int J Pharm. 2014 Dec 30;477(1-2):623-30. doi: 10.1016/j.ijpharm.2014.11.005. Epub 2014 Nov 6.

PMID:
25445973
3.

Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats.

Elmowafy E, Osman R, El-Shamy AH, Awad GA.

Int J Nanomedicine. 2014 Sep 18;9:4449-65. doi: 10.2147/IJN.S66876. eCollection 2014.

4.

Impact of microparticle formulation approaches on drug burst release: a level A IVIVC.

Ishak RA, Mortada ND, Zaki NM, El-Shamy Ael-H, Awad GA.

J Microencapsul. 2014;31(7):674-84. doi: 10.3109/02652048.2014.913724. Epub 2014 Jun 25.

PMID:
24963960
5.

Nasal polysaccharides-glucose regulator microparticles: optimization, tolerability and antidiabetic activity in rats.

Elmowafy E, Osman R, El-Shamy Ael-H, Awad GA.

Carbohydr Polym. 2014 Aug 8;108:257-65. doi: 10.1016/j.carbpol.2014.02.064. Epub 2014 Feb 28.

PMID:
24751272
6.

Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo.

El-Gogary RI, Rubio N, Wang JT, Al-Jamal WT, Bourgognon M, Kafa H, Naeem M, Klippstein R, Abbate V, Leroux F, Bals S, Van Tendeloo G, Kamel AO, Awad GA, Mortada ND, Al-Jamal KT.

ACS Nano. 2014 Feb 25;8(2):1384-401. doi: 10.1021/nn405155b. Epub 2014 Jan 23.

PMID:
24397686
7.

Chlorpromazine versus placebo for schizophrenia.

Adams CE, Awad GA, Rathbone J, Thornley B, Soares-Weiser K.

Cochrane Database Syst Rev. 2014 Jan 6;1:CD000284. doi: 10.1002/14651858.CD000284.pub3. Review.

PMID:
24395698
8.

Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging.

Sakr TM, El-Safoury DM, Awad GA, Motaleb MA.

J Labelled Comp Radiopharm. 2013 Jun 30;56(8):392-5. doi: 10.1002/jlcr.3060. Epub 2013 May 22.

PMID:
24285479
9.
10.

A comparative study of chitosan shielding effect on nano-carriers hydrophilicity and biodistribution.

Ishak RA, Awad GA, Zaki NM, El-Shamy Ael-H, Mortada ND.

Carbohydr Polym. 2013 Apr 15;94(1):669-76. doi: 10.1016/j.carbpol.2013.01.072. Epub 2013 Feb 8.

PMID:
23544589
11.

Brain delivery of olanzapine by intranasal administration of transfersomal vesicles.

Salama HA, Mahmoud AA, Kamel AO, Abdel Hady M, Awad GA.

J Liposome Res. 2012 Dec;22(4):336-45. doi: 10.3109/08982104.2012.700460. Epub 2012 Aug 13.

PMID:
22881283
12.

Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route.

Salama HA, Mahmoud AA, Kamel AO, Abdel Hady M, Awad GA.

Colloids Surf B Biointerfaces. 2012 Dec 1;100:146-54. doi: 10.1016/j.colsurfb.2012.05.010. Epub 2012 May 24.

PMID:
22766291
13.

Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium.

Nasr M, Awad GA, Mansour S, Al Shamy A, Mortada ND.

Pharm Dev Technol. 2013 Sep-Oct;18(5):1078-88. doi: 10.3109/10837450.2012.693507. Epub 2012 Jun 2.

PMID:
22656315
14.

Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan.

Mekhail GM, Kamel AO, Awad GA, Mortada ND.

Int J Biol Macromol. 2012 Nov;51(4):351-63. doi: 10.1016/j.ijbiomac.2012.05.026. Epub 2012 May 29.

PMID:
22652220
15.

Does treatment adherence correlates with health related quality of life? Findings from a cross sectional study.

Saleem F, Hassali MA, Shafie AA, Awad GA, Atif M, ul Haq N, Aljadhey H, Farooqui M.

BMC Public Health. 2012 Apr 30;12:318. doi: 10.1186/1471-2458-12-318.

16.

Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.

Nasr M, Awad GA, Mansour S, Taha I, Al Shamy A, Mortada ND.

Eur J Pharm Biopharm. 2011 Nov;79(3):601-11. doi: 10.1016/j.ejpb.2011.07.010. Epub 2011 Jul 29.

PMID:
21827854
17.

A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres.

Nasr M, Awad GA, Mansour S, Al Shamy A, Mortada ND.

J Pharm Sci. 2011 Feb;100(2):612-21. doi: 10.1002/jps.22297. Epub 2010 Aug 26.

PMID:
20799365
18.

Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.

El Zaafarany GM, Awad GA, Holayel SM, Mortada ND.

Int J Pharm. 2010 Sep 15;397(1-2):164-72. doi: 10.1016/j.ijpharm.2010.06.034. Epub 2010 Jul 3.

PMID:
20599487
19.

Preparation of intravenous stealthy acyclovir nanoparticles with increased mean residence time.

Kamel AO, Awad GA, Geneidi AS, Mortada ND.

AAPS PharmSciTech. 2009;10(4):1427-36. doi: 10.1208/s12249-009-9342-y. Epub 2009 Dec 1.

20.

Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers.

Elshafeey AH, Kamel AO, Awad GA.

Colloids Surf B Biointerfaces. 2010 Feb 1;75(2):398-404. doi: 10.1016/j.colsurfb.2009.08.050. Epub 2009 Sep 6.

PMID:
19853420
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk